Americord Registry (www.americordblood.com) is the leader in the advancement of umbilical cord blood, cord tissue and placenta banking. Americord collects, processes and stores newborn stem cells from umbilical cord for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified, accredited by AABB and complies with all federal and state guidelines and applicable licenses. Headquarter in New York City, Americord has been recognized as one of INC’s 500 Fastest Growing Companies of 2015.